Herein, we found that targeting RNF219/α‐catenin/LGALS3 axis, such as LGALS3 neutralizing antibody or YAP inhibitor verteporfin, could effectively inhibit HCC‐BM in nude mice. This evidence concerns the gene LGALS3 and hepatocellular carcinoma.